Valeant Pharmaceuticals reported CAD1.63B in Operating Expenses for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Amgen AMGN:US $ 4.42B 680M
Ani Pharmaceuticals ANIP:US $ 86.77M 3.1M
Aurora Cannabis Inc ACB:CN 1.05B 921.9M
Biogen BIIB:US $ 2648.2M 727.1M
Bristol Myers Squibb BMY:US $ 9.3B 202M
Canopy Growth Corp WEED:CN C$ 1.95B 1.3B
Catalent CTLT:US $ 1.06B 6M
Corcept Therapeutics CORT:US $ 71.95M 5.04M
Danaher DHR:US $ 5546M 30M
Eli Lilly And LLY:US $ 5277.9M 127.8M
Gilead Sciences GILD:US $ 4231M 2162M
Horizon Pharma HZNP:US $ 787.85M 96.93M
JAZZ PHA JAZZ:US $ 847.33M 121.16M
Lannett LCI:US $ 100.44M 54.15M
Nektar Therapeutics NKTR:US $ 174.42M 33.04M
Pacira Pharmaceuticals PCRX:US $ 138.18M 2.42M
Perrigo Ordinary Shares PRGO:US $ 1137.9M 85.1M
Phibro Animal Health PAHC:US $ 220.42M 10.01M
Prestige Brands PBH:US $ 190.04M 534K
Revance Therapeutics RVNC:US $ 86.21M 1.27M
Supernus Pharmaceuticals SUPN:US $ 158.7M 8.17M
Valeant Pharmaceuticals VRX:CN C$ 1.63B 196M
Vertex Pharmaceuticals VRTX:US $ 1089.9M 33.3M
Zoetis ZTS:US $ 1.38B 123M